Matinas Biopharma Holdings Inc Stock News
$0.179
-0.0026 (-1.43%)
At Close: Apr 26, 2024
The Week Ahead In Biotech (March 8-14): Bristol-Myers Awaits FDA Nod For Liver Cancer Combo Therapy, Earnings Flow Continues
08:14pm, Sunday, 08'th Mar 2020
Biotech stocks rebounded in the week ended March 6, recovering from the previous week's steep sell-off.
The week was light on news flow, barring some smid-cap earnings and...
The Week Ahead In Biotech (March 8-14): Bristol-Myers Awaits FDA Nod For Liver Cancer Combo Therapy, Earnings Flow Continues
12:00am, Sunday, 08'th Mar 2020
Biotech stocks rebounded in the week ended March 6, recovering from the previous week's steep sell-off.
The week was light on news flow, barring some smid-cap earnings and...
Analysts Offer Insights on Healthcare Companies: Matinas BioPharma (MTNB) and Xeris Pharmaceuticals (XERS)
01:13pm, Friday, 06'th Mar 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Matinas BioPharma (MTNB) and Xeris Pharmaceuticals (XERS)
Matinas BioPharma Announces Initiation of ENHANCE-IT Study of MAT9001 Against Vascepa®
12:00pm, Thursday, 05'th Mar 2020
Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), today announced that it has initiated the ENHANCE-IT Study (Pharmacodynamic Effects of a Free Fatty Acid Formulation of Omega-3 Pentaenoic Acids to
Matinas BioPharma Appoints James A. Underberg, M.D. to its MAT9001 Scientific Advisory Board
12:00pm, Wednesday, 04'th Mar 2020
Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB) today announced the appointment of James A. Underberg, M.D., M.S., FACPM, FACP, FNYAM, FASPC, FNLA to its Scientific Advisory Board (SAB). Dr. Under
Confounding Decline Creates an Opportunity in Amarin Stock
03:07pm, Friday, 28'th Feb 2020
Amarin stock has declined by nearly a quarter so far in 2020 on little news. That lower valuation makes AMRN intriguing.
Matinas BioPharma Holdings, Inc. (“Matinas BioPharma” or the “Company”) -- (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company, today announced that the Company will host a conferenc
Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), today announced that the independent Data Safety Monitoring Board (DSMB) for the EnACT study has completed its planned review of initial safety and
Analysts: These 3 Penny Stocks Are Positioned for Big Gains in 2020
03:08pm, Wednesday, 12'th Feb 2020
Penny stocks, you either love them or you hate them. One of the obvious draws of these stocks trading for under $5 per share is the ability to get more bang for your buck. And should these bargain pri
5 Stocks Under $5 With Colossal Growth Prospects
04:14pm, Friday, 31'st Jan 2020
Investors want to see a return on investment, it's as simple as that. Regardless of the size of the investment, the end goal remains the same. Sure, there are several ways to go about achieving this o
Prospects Appear Bright for Small Drug Industry in 2020
01:41pm, Tuesday, 21'st Jan 2020
Prospects Appear Bright for Small Drug Industry in 2020
Prospects Appear Bright for Small Drug Industry in 2020
01:41pm, Tuesday, 21'st Jan 2020
Successful innovation resulting in new drug approvals, important advances in clinical studies, frequent collaborations and M&A activity keep small drugmakers afloat in a competitive market.
Cara Therapeutics named a BioPharma top pick for 2020 at Stifel CARA;HZNP;EOLS
02:14pm, Friday, 10'th Jan 2020
Cara Therapeutics named a BioPharma top pick for 2020 at Stifel Stifel CARA HZNP EOLS
